Scientific Strategy
Grant writing (EIC/Horizon, SBIR), study design, regulatory pathway navigation, and IND-enabling program oversight.
Learn More24+ years in glycobiology and the M6P pathway
Glyko Consulting has spent over two decades working at the intersection of glycobiology, enzyme replacement therapy, and rare disease drug development. We work with biotech companies, foundations, and research institutions to guide programs through regulatory pathways, coordinate multi-stakeholder efforts, and build strategies that move therapies closer to patients.
“We bring scientific strategy and dedicated program stewardship to every rare disease program we work on.”
Grant writing (EIC/Horizon, SBIR), study design, regulatory pathway navigation, and IND-enabling program oversight.
Learn MoreFull program management across multi-partner collaborations, milestone tracking, and team coordination.
Learn MoreFoundation engagement (ForeBatten, Lost Enzyme), patient organization strategy, and advocacy-driven development plans.
Learn MoreFrom first preclinical experiments through IND submission and beyond, we bring the regulatory intelligence, scientific depth, and coordinated teamwork your program needs to move forward with confidence.
Discuss your programLet's discuss how we can accelerate your program.
We typically respond within 24 hours.